Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decatecholaminization with methylene blue ± dexmedetomidine in septic shock with tachycardia
TCTR20260321007Phase 2Not yet recruiting
- Sponsor
- Mahidol University
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylene blue, dexmedetomidine in septic shock, sponsored by Mahidol University. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
methylene bluedexmedetomidine
03
Conditions
septic shock
Beyond the preview
Go deeper on TCTR20260321007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260321007.